ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.

Asymchem Laboratories (Tianjin) Co., Ltd.

002821

CNE100002BZ6

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
76.86 ^CNY	-0.59%		-1.98%	-33.80%

10:45am	Nomura Adjusts Asymchem Laboratories’ Price Target to HK$83.94 From HK$90.12 Keeps at Buy	MT
10:45am	Nomura Adjusts Asymchem Laboratories’ Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy	MT

Asymchem Laboratories Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 21 July 2022

May 13, 2022 at 07:15 am EDT

Asymchem Laboratories (Tianjin) Co., Ltd. proposed final dividend for the year ended 31 December 2021 of RMB 8 per 10 share. Ex-dividend date is 13 June 2022. Record date is 22 June 2022.

Payment date is 21 July 2022.

Latest news about Asymchem Laboratories (Tianjin) Co., Ltd.

Nomura Adjusts Asymchem Laboratories’ Price Target to HK$83.94 From HK$90.12 Keeps at Buy	04:45am	MT
Nomura Adjusts Asymchem Laboratories’ Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy	04:45am	MT
Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Tranche Update on Asymchem Laboratories Co., Ltd.'s Equity Buyback Plan announced on March 8, 2024.	Apr. 02	CI
Asymchem Laboratories' Profit Falls 31% as Revenue Drops 24% in 2023	Mar. 29	MT
Asymchem Laboratories Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended 31 December 2023	Mar. 28	CI
Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Asymchem Laboratories Completes A-Share Repurchase Program	Mar. 27	MT
Asymchem Laboratories Co., Ltd. commences an Equity Buyback Plan for CNY 1,200 million worth of its shares, under the authorization approved on February 29,2024.	Mar. 07	CI
Nomura Adjusts Asymchem Laboratories Tianjin’s Price Target to HK$90.12 From HK$134.59, Keeps at Buy	Mar. 04	MT
Nomura Adjusts Asymchem Laboratories (Tianjin)’s Price Target to 127.21 Yuan From 189.98 Yuan, Keeps at Buy	Mar. 04	MT
Asymchem Laboratories Co., Ltd. Appoints Hou Xinyi as an Independent Non-Executive Director, Effective 29 February 2024	Feb. 29	CI
Asymchem Laboratories Co., Ltd. Announces Resignation of Wang Qingsong as Independent Non-Executive Director and Committees	Feb. 05	CI
Asymchem's Shenzhen Shares Jump 7% on 1.2 Billion Yuan Stock Buyback	Feb. 01	MT
INSTANT VIEW 8-China Evergrande ordered to liquidate by Hong Kong court	Jan. 29	RE
Chinese Shares Retreat to Four-Year Lows Ahead of Trade, Inflation Data; Bolong Equipment Surges 17% in Shanghai Debut	Jan. 10	MT
China's policy dilemma: is boosting credit deflationary?	Jan. 10	RE
Asymchem Laboratories To Buy Back Over 100,000 Shares	Dec. 26	MT
Chinese Shares End Lower as Economic Roadmap Disappoints; Fengmao Technology Surges 86% in Shenzhen Debut	Dec. 13	MT
Asymchem Laboratories Records 47% Drop in Q3 Profit	23-10-31	MT
Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$134.59 From HK$130.30, Keeps at Buy	23-10-25	MT
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 189.98 Yuan From 160.07 Yuan, Keeps at Buy	23-10-25	MT
Asymchem Laboratories Co., Ltd. Appoints Sun Xuejiao as Independent Non-Executive Director	23-09-13	CI
Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI

Chart Asymchem Laboratories (Tianjin) Co., Ltd.

Duration

Period

Chart Asymchem Laboratories (Tianjin) Co., Ltd.

More charts

Asymchem Laboratories (Tian Jin) Co Ltd is a China-based company mainly engaged in the contract development manufacturing organization (CDMO) of drugs. The Company's main businesses are the process development, amplification and commercialization of chemical drugs. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company is also engaged in the provision of pharmaceutical formulation solutions, biosynthetic solutions and clinical solutions.

Sector

Pharmaceuticals

Calendar

2024-08-14 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Asymchem Laboratories (Tianjin) Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

80.99 CNY

Average target price

112.1 CNY

Spread / Average Target

+38.47%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.	-33.80%	3.71B
ELI LILLY AND COMPANY	+26.39%	653B
NOVO NORDISK A/S	+27.00%	556B
JOHNSON & JOHNSON	-6.44%	354B
MERCK & CO., INC.	+20.40%	331B
ABBVIE INC.	+3.89%	296B
ASTRAZENECA PLC	+13.09%	233B
NOVARTIS AG	+5.46%	201B
ROCHE HOLDING AG	-9.61%	193B
AMGEN INC.	-6.20%	144B

Other Pharmaceuticals

Asymchem Laboratories (Tianjin) Co., Ltd.

Equities

002821

CNE100002BZ6

Pharmaceuticals

Asymchem Laboratories Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, Payable on 21 July 2022

Latest news about Asymchem Laboratories (Tianjin) Co., Ltd.

Chart Asymchem Laboratories (Tianjin) Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Asymchem Laboratories (Tianjin) Co., Ltd.

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Pharmaceuticals